So, no single medication is a one-size-fits-all treatment for chronic weight management
Researchers affiliated with the Karolinska Institute and Stockholm University, both in Sweden, have developed a new drug that treats type 2 diabetes and obesity without impacting muscle mass
Patients should discuss risks carefully if they have: A history of pancreatitis Severe nausea, vomiting, or gastroparesis Gallbladder disease Severe dehydration risk Advanced kidney disease with frequent vomiting or poor oral intake A personal or family history of medullary thyroid cancer Multiple endocrine neoplasia syndrome type 2 Pregnancy, plans for pregnancy, or breastfeeding Also, if you have active lupus nephritis or unstable lupus, your rheumatologist and nephrologist should be involved before starting any new medicine that could affect hydration, nutrition, kidney function, or medication tolerance
CJC-1295, a growth hormone-releasing hormone analog, extends the release of GH, ensuring a sustained elevation in GH levels
Supplementary material The Supplementary Material for this article can be found online at: SUPPLEMENTARY FIGURE 1 Experimental models for (A) Bovine granulosa cell in vitro culture